During the past decade, Palo Alto Medical Foundation-Camino Division conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 69 clinical trials were completed, i.e. on average, 78.4% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 49 clinical trials were completed. i.e. 204.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Medical Foundation-Camino Division" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "GOG Foundation" with 7 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation-Camino Division" #1 collaborator was "National Cancer Institute (NCI)" with 61 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation-Camino Division" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "Palo Alto Medical Foundation-Camino Division" in a lesser frequency.

Most popular intervention types in "Palo Alto Medical Foundation-Camino Division" are "Drug" (116 trials), "Other" (96 trials), "Biological" (60 trials), "Procedure" (36 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (20 trials), "Biospecimen Collection" (17 trials) and "Paclitaxel" (17 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Medical Foundation-Camino Division" are 107 trials for "All" genders, 31 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Palo Alto Medical Foundation-Camino Division". undefined are not yet recruiting, 26 are recruiting, 72 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Palo Alto Medical Foundation-Camino Division, 3 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Medical Foundation-Camino Division, 3 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".